VILINBIO2026-08-10VILINBIO2026-08-102026-08-10RelatedPartyTransactionDomain1VILINBIO2026-08-102026-08-10RelatedPartyTransactionDomain2VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain1VILINBIO2026-08-10ResolutionOrAgendaDomain1VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain2VILINBIO2026-08-10ResolutionOrAgendaDomain2VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain3VILINBIO2026-08-10ResolutionOrAgendaDomain3VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain4VILINBIO2026-08-10ResolutionOrAgendaDomain4VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain5VILINBIO2026-08-10ResolutionOrAgendaDomain5VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain6VILINBIO2026-08-10ResolutionOrAgendaDomain6VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain7VILINBIO2026-08-10ResolutionOrAgendaDomain7VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain8VILINBIO2026-08-10ResolutionOrAgendaDomain8VILINBIO2026-08-102026-08-10ResolutionOrAgendaDomain9VILINBIO2026-08-10ResolutionOrAgendaDomain9iso4217:INRxbrli:pureVILINBIOVILIN BIO MED LIMITEDNew2026-08-1014:00:002026-08-10Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)20th Annual General MeetingWednesday2026-09-0215:00:00Video Conference (VC) or Other Audio-Visual Means (OAVM)9Vilin Bio Med LimitedVilo Speciality Pharma Private LimitedWholly Owned SubsidiarySale of goods or services5000000002026-08-012027-03-31NAVilin Bio Med LimitedAxia Pharma Private LimitedWholly Owned SubsidiarySale of goods or services5000000002026-08-012027-03-31NAOrdinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the Standalone Audited Financial Statements of the Company for the Financial Year ended March 31, 2026 together with the Board's Report and Auditors' Report thereonOrdinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo appoint a Director in place of Ms. Prasanna Lakshmi Venna (DIN: 10862263), who retires by rotation at this Annual General Meeting, in terms of Section 152 of the Companies Act, 2013 and being eligible, has offered herself for re-appointmentExecutive DirectorPrasanna Lakshmi Venna108622632025-01-102030-01-09Special ResolutionOthersOthersSection 180(1)(c) of the Companies Act, 2013Approval to borrow Monies in Excess of Paid-up Capital and Free Reserves under Section 180(1)(c) of the Companies Act, 2013Special ResolutionOthersOthersSection 180(1)(a) of the Companies Act, 2013Approval to Create Charge / Security on Company Assets under Section 180(1)(a) of the Companies Act, 2013Special ResolutionOthersOthersSections 185 and 186 of the Companies Act, 2013Approval for Loans, Investments, Guarantees and Securities under Sections 185 and 186 of the Companies Act, 2013Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationAppointmentAppointment of M/s Pawan Jain & Associates as Secretarial Auditors of the CompanyOthersSecretarial AuditorsM/s Pawan Jain & Associates2026-04-012031-03-31Ordinary ResolutionRelated Party TransactionApproval of Material Related Party Transaction to be entered M/s Vilo Speciality Pharma Private Limited (Wholly Owned Subsidiary)Ordinary ResolutionRelated Party TransactionApproval of Material Related Party Transaction to be entered into with M/s Axia Pharma Private Limited (Wholly Owned Subsidiary)Ordinary ResolutionRelated Party TransactionRatification of Material Related Party Transactions for FY 2025–2026: